Patent · US Active

Evolved interferon-alpha polypeptides

US7619067B2 · kind B2 · utility

8Cited by

13References

18Claims

0Family size

Assignee

Maxygen, Inc. · US

Inventors

Madan M. Paidhungat · San Francisco, US
Ian J. Sas · Redwood City, US
Thomas Bouquin · Allested, DK
David M. Lin · Ithaca, US
Teddy Chen · Austin, US
Douglas Guptill · Mountain View, US
Amy Brideau-Andersen · Irvine, US
Steven H. Bass · Hillsborough, US
Phillip A. Patten · Portola Valley, US

Key dates

Filing date	May 17, 2006
Grant date	Nov 17, 2009
Priority date	—
Expiry date	Jan 5, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides evolved interferon-alpha polypeptides, and conjugates thereof, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.